Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

N. Ginsberg, Henry; J. Packard, Chris; John Chapman, M.; Borén, Jan; A. Aguilar‐Salinas, Carlos; Averna, Maurizio; A. Ference, Brian; Gaudet, Daniel; A. Hegele, Robert; Kersten, Sander; F. Lewis, Gary; H. Lichtenstein, Alice; Moulin, Philippe; G. Nordestgaard, Børge; T. Remaley, Alan; Staels, Bart; S.G. Stroes, Erik; Taskinen, Marja‐Riitta; Tokgözoğlu, Lâle; Tybjærg‐Hansen, Anne; K. Stock, Jane; L. Catapano, Alberico

doi:10.1093/eurheartj/ehab551

Public

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Published in European Heart Journal • Jul 30, 2021

Authors:

Henry N. Ginsberg

Chris J. Packard

M. John Chapman

Abstract

Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic st...

Subject

Medicine

Lipoprotein

Myocardial infarction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!